Individual differences mean that the costs of treatment of hypertension cannot readily be quantified
Cardiovasc Drugs Ther
.
1990 Dec;4(6):1439-41.
doi: 10.1007/BF02026488.
Author
N M Kaplan
PMID:
2081136
DOI:
10.1007/BF02026488
No abstract available
Publication types
Editorial
MeSH terms
Antihypertensive Agents*
Contraindications
Humans
Hypertension / economics*
Substances
Antihypertensive Agents